In a new study, an international team led by the University of Bonn identified and further developed the novel single-domain antibodies (sdAbs) against SARS-CoV-2. The researchers also combined these single-domain antibodies intoRead More…
Most CAR-T cell therapies require targeting cancer cell-specific antigens. Now, there is a new way to target the environment around the tumor, which comes from nanobodies naturally produced by free alpacas, camelsRead More…
Introduction Single domains represent the smallest known fragment still capable of binding antigen that can be isolated from a full-sized immunoglobulin. In work on the cloning of antibody genes and construction ofRead More…
The first single domain antibody engineered from the heavy-chain antibodies and found in camelids has greatly stimulated the development of antibody market. The Rapid Development of Antibody Drugs Except brain, the mostRead More…
As is known, antibody can be regarded as a specific protein that produced in response to counteracting an unique antigen, which is usually used to recognize and resist the invaders. It canRead More…